Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
20.23
+0.36 (1.81%)
Nov 5, 2025, 4:00 PM EST - Market closed
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $13.98 billion as of November 6, 2025. Its market cap has increased by 62.65% in one year.
Market Cap
13.98B
Enterprise Value
9.57B
1-Year Change
62.65%
Ranking
Category
Stock Price
$20.23
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $13.98B, an increase of 2,520.42%. That is a compound annual growth rate of 94.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 13.98B | 62.30% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
| Dec 8, 2020 | 533.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 811.99B |
| Johnson & Johnson | 450.20B |
| AbbVie | 381.38B |
| UnitedHealth Group | 299.68B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.75B |
| Novo Nordisk | 215.64B |